Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic

Shivani Agarwal, Justin Mathew, Georgia M Davis, Alethea Shephardson, Ann Levine, Rita Louard, Agustina Urrutia, Citlalli Perez-Guzman, Guillermo E Umpierrez, Limin Peng, Francisco J Pasquel, Shivani Agarwal, Justin Mathew, Georgia M Davis, Alethea Shephardson, Ann Levine, Rita Louard, Agustina Urrutia, Citlalli Perez-Guzman, Guillermo E Umpierrez, Limin Peng, Francisco J Pasquel

Abstract

Objective: Real-time continuous glucose monitoring (rtCGM) in critically ill hospitalized patients holds promise; however, real-world data are needed.

Research design and methods: We placed Dexcom G6 CGM on intensive care unit (ICU) patients at Montefiore Medical Center with confirmed coronavirus disease 2019 (COVID-19) infection and glycemic variability. We analyzed inpatient CGM accuracy using point-of-care (POC) glucose-CGM matched pairs and included patients for analysis regardless of clinical status.

Results: We included 11 patients with CGM: 8 on continuous insulin infusion (CII), 8 on vasopressors, 8 intubated, 4 on high-dose glucocorticoids, 6 on renal replacement therapy, and 2 with anasarca. Accuracy was 12.58% for mean and 6.3% for median absolute relative difference. CGM reduced POC testing by ∼60% for patients on CII.

Conclusions: In this real-world preliminary analysis of rtCGM during critical illness, we demonstrate early feasibility, considerable accuracy, and meaningful reduction in the frequency of POC glucose testing.

© 2020 by the American Diabetes Association.

Figures

Figure 1
Figure 1
Clarke error grid analysis showing the relationship between CGM and POC glucose values in critically ill patients with COVID-19 (n = 11).

References

    1. Galindo RJ, Aleppo G, Klonoff DC, et al. . Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol 2020;14:822–832
    1. Reutrakul S, Genco M, Salinas H, et al. . Feasibility of inpatient continuous glucose monitoring during the COVID-19 pandemic: early experience. Diabetes Care 2020;43:e137–e138
    1. Shehav-Zaltzman G, Segal G, Konvalina N, Tirosh A. Remote glucose monitoring of hospitalized, quarantined patients with diabetes and COVID-19. Diabetes Care 2020;43:e75–e76
    1. Ushigome E, Yamazaki M, Hamaguchi M, et al. . Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes. Diabetes Technol Ther 2021;23:78–80
    1. Pasquel FJ, Umpierrez GE. Individualizing inpatient diabetes management during the coronavirus disease 2019 pandemic. J Diabetes Sci Technol 2020;14:705–707
    1. Garg SK, Akturk HK. A new era in continuous glucose monitoring: Food and Drug Administration creates a new category of factory-calibrated nonadjunctive, interoperable class II medical devices. Diabetes Technol Ther 2018;20:391–394
    1. Shah VN, Laffel LM, Wadwa RP, Garg SK. Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator. Diabetes Technol Ther 2018;20:428–433
    1. Freckmann G, Pleus S, Grady M, Setford S, Levy B. Measures of accuracy for continuous glucose monitoring and blood glucose monitoring devices. J Diabetes Sci Technol 2019;13:575–583
    1. Clarke W, Kovatchev B. Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther 2009;11(Suppl. 1):S45–S54
    1. Nair BG, Dellinger EP, Flum DR, Rooke GA, Hirsch IB. A pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring. Diabetes Care 2020;43:e168–e169
    1. Tripyla A, Herzig D, Joachim D, et al. . Performance of a factory-calibrated, real-time continuous glucose monitoring system during elective abdominal surgery. Diabetes Obes Metab 2020;22:1678–1682
    1. Davis GM, Galindo RJ, Migdal AL, Umpierrez GE. Diabetes technology in the inpatient setting for management of hyperglycemia. Endocrinol Metab Clin North Am 2020;49:79–93
    1. Galindo RJ, Migdal AL, Davis GM, et al. . Comparison of the FreeStyle Libre Pro Flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with basal-bolus insulin regimen. Diabetes Care 2020;43:2730–2735
    1. Ancona P, Eastwood GM, Lucchetta L, Ekinci EI, Bellomo R, Mårtensson J. The performance of flash glucose monitoring in critically ill patients with diabetes. Crit Care Resusc 2017;19:167–174

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する